• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药药物警戒体系的历史进程、现状与未来发展

Historical Process, Status and Future Development of Pharmacovigilance Systems in Chinese Medicine.

作者信息

Wang Xue, Wang Yinfeng, Zhang Xiaomeng, Zhang Bing, Lin Zhijian

机构信息

Department of Clinical Chinese Pharmacy, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China.

Research Center for Pharmacovigilance and Rational Use of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

Pharmacy (Basel). 2025 Jun 26;13(4):90. doi: 10.3390/pharmacy13040090.

DOI:10.3390/pharmacy13040090
PMID:40700261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12286246/
Abstract

The definition of pharmacovigilance was first proposed in the 1970s to safeguard public health and the safety of drug use, and to improve the quality of life of patients. China's traditional medicine has also always contained the idea of vigilance for the safe use of medicines in the process of development. In this article, we will discuss the origin and development of the idea of pharmacovigilance in China, the establishment of a realistic system, and the current status of pharmacovigilance construction, and look forward to the development of pharmacovigilance in the future.

摘要

药物警戒的定义最早于20世纪70年代提出,旨在保障公众健康和用药安全,并提高患者的生活质量。中国传统医学在发展过程中也始终蕴含着用药安全警戒的理念。在本文中,我们将探讨中国药物警戒理念的起源与发展、切实可行的体系建立以及药物警戒建设的现状,并展望药物警戒的未来发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/12286246/197928b97d20/pharmacy-13-00090-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/12286246/5a988b2ef20c/pharmacy-13-00090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/12286246/197928b97d20/pharmacy-13-00090-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/12286246/5a988b2ef20c/pharmacy-13-00090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/160a/12286246/197928b97d20/pharmacy-13-00090-g002.jpg

相似文献

1
Historical Process, Status and Future Development of Pharmacovigilance Systems in Chinese Medicine.中医药药物警戒体系的历史进程、现状与未来发展
Pharmacy (Basel). 2025 Jun 26;13(4):90. doi: 10.3390/pharmacy13040090.
2
Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.低收入和中等收入国家的药物警戒流程:从数据收集转向数据分析与解读
Ther Adv Drug Saf. 2025 Jun 11;16:20420986241300006. doi: 10.1177/20420986241300006. eCollection 2025.
3
Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries.建立功能完善且可持续的药物警戒系统:对高、中、低收入国家药物警戒发展情况的分析
Ther Adv Drug Saf. 2025 Jun 10;16:20420986251342941. doi: 10.1177/20420986251342941. eCollection 2025.
4
Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.监测网络论坛中的药物不良事件:一个管道的评估和应用案例研究。
J Med Internet Res. 2024 Jun 18;26:e46176. doi: 10.2196/46176.
5
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
6
Chinese herbal medicine for oesophageal cancer.用于食管癌的中草药。
Cochrane Database Syst Rev. 2016 Jan 22;2016(1):CD004520. doi: 10.1002/14651858.CD004520.pub7.
7
The role of systematic reviews in pharmacovigilance planning and Clinical Trials Authorisation application: example from the SLEEPS trial.系统评价在药物警戒计划和临床试验授权申请中的作用:来自 SLEEPS 试验的示例。
PLoS One. 2013;8(3):e51787. doi: 10.1371/journal.pone.0051787. Epub 2013 Mar 15.
8
Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database.免疫检查点抑制剂相关心脏免疫不良事件中的性别和年龄差异:FAERS数据库的药物警戒分析
BMJ Open. 2025 Jun 12;15(6):e090087. doi: 10.1136/bmjopen-2024-090087.
9
Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study.挖掘真实世界大数据以定量表征药物不良反应:混合方法研究
J Med Internet Res. 2024 May 3;26:e48572. doi: 10.2196/48572.
10
Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.患者与医疗保健专业人员自发药物不良反应报告:系统评价。
Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.1007/BF03261977.

本文引用的文献

1
[Enlightenment of international pharmacovigilance system on establishment of pharmacovigilance system of Chinese medicine].[国际药物警戒体系对我国中药药物警戒体系建设的启示]
Zhongguo Zhong Yao Za Zhi. 2021 Nov;46(21):5450-5455. doi: 10.19540/j.cnki.cjcmm.20210918.501.
2
[Pharmacovigilance in materia medica works of Qing Dynasty].清代本草著作中的药物警戒
Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(21):4751-4755. doi: 10.19540/j.cnki.cjcmm.20190812.502.
3
The toxicity and safety of traditional Chinese medicines: Please treat with rationality.
中药的毒性与安全性:请理性对待。
Biosci Trends. 2019 Nov 13;13(5):367-373. doi: 10.5582/bst.2019.01244. Epub 2019 Sep 30.
4
Utilizing social media data for pharmacovigilance: A review.利用社交媒体数据进行药物警戒:综述
J Biomed Inform. 2015 Apr;54:202-12. doi: 10.1016/j.jbi.2015.02.004. Epub 2015 Feb 23.
5
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.年轻女性快速进展性间质性肾纤维化:与包括中草药在内的减肥方案的关联。
Lancet. 1993 Feb 13;341(8842):387-91. doi: 10.1016/0140-6736(93)92984-2.